Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 91 results found. Search for [ by P.B. Jayakumar ]

Results 80 to 91 of 91
PB Jayakumar
May 5, 2015
Wockhardt Chairman Habil Khorakiwala speaks with P.B. Jayakumar about the company's recent decision to recall some drugs from the US and how the drug maker is trying to resolve issues related to the US FDA.


P.B. Jayakumar
May 18, 2015
Industry observers feel it would take a lot of effort for Wockhardt to regain its glory and it won't be easy considering the company's business mix, strategies and product portfolio.


P.B. Jayakumar
April 9, 2015
Independent sources said the chain has a turnover of about Rs 550 crore and was valued between Rs 1,500 crore and Rs 1,800 crore a few months ago.


P.B. Jayakumar
April 7, 2015
The earlier-than-expected capacity addition is due to high demand for solar equipment in the country and Rolta Power is already sitting on Rs 80-crore order book, said Managing Director Aditya K. Singh.


P.B. Jayakumar
April 1, 2015
The product, launched for patients in seven countries in Europe since September, has already been used by over 15,000 patients, said Robert Ford, senior vice-president, Diabetes Care, Abbott.


P.B. Jayakumar
March 27, 2015
Exports of food and drugs to the US from India have increased over the years and that warrants more inspections and scrutiny by the FDA.


PB Jayakumar
March 26, 2015
Soon Ranbaxy Laboratories will cease to exist as the company is merging with Sun Pharmaceutical Industries.


PB Jayakumar
March 24, 2015
Aarti Drugs said on Tuesday that two of its facilities in Tarapur received an import alert on March 23 as per the FDA website.


P.B. Jayakumar
March 5, 2015
\"This deal should be viewed as a precursor to many such deals going to happen in this sector,\" says Sanjay Sethi, who runs Nector Consulting and was the senior executive director and head of infrastructure Group at Kotak Investment Banking.


P.B. Jayakumar
March 3, 2015
The deal does many things for Suzlon. It infuses Rs 1,800 crore of much-needed cash at a time its quarterly net loss is 17 times its sales. Secondly, it brings Sun Pharma's Dilip Shanghvi into the mix.


P.B. Jayakumar
March 5, 2015
The US is mounting pressure on India to agree to its terms in pharma IP protection. How long can India resist?


P.B. Jayakumar
January 9, 2015
Scomi and three to five of its key vendor associates will invest over Rs 1,000 crore in BAPL to make rakes and logistics infrastructure for various mass rapid transport systems like monorail, buses, metro and tram services.


PAGES 5 OF 5  12345